Notifications for Japan (1406 notifications)

Reset

The proposed maximum residue limits (MRLs) for Sulfadoxine notified in G/SPS/N/JPN/1287 (dated 9 September 2024) were adopted and published on 10 February 2025.The specified MRLs are available as below:

Maximum residue limits (MRLs); +17

The proposed maximum residue limits (MRLs) for Sulfamoyldapsone notified in G/SPS/N/JPN/1290 (dated 9 September 2024) were adopted and published on 10 February 2025.The specified MRLs are available as below:

Maximum residue limits (MRLs); +17

The proposed maximum residue limits (MRLs) for Flometoquin notified in G/SPS/N/JPN/1279 (dated 9 September 2024) were adopted and published on 10 February 2025.The specified MRLs are available as below:

Maximum residue limits (MRLs); +17

The proposed maximum residue limits (MRLs) for Pyribencarb notified in G/SPS/N/JPN/1280 (dated 9 September 2024) were adopted and published on 10 February 2025.The specified MRLs are available as below:

Maximum residue limits (MRLs); +17

The proposed maximum residue limits (MRLs) for Sulfadiazine notified in G/SPS/N/JPN/1284 (dated 9 September 2024) were adopted and published on 10 February 2025.The specified MRLs are available as below:

Maximum residue limits (MRLs); +17

The proposed maximum residue limits (MRLs) for Sulfamonomethoxine notified in G/SPS/N/JPN/1289 (dated 9 September 2024) were adopted and published on 10 February 2025.The specified MRLs are available as below:

Maximum residue limits (MRLs); +17

The proposed maximum residue limits (MRLs) for Sulfaquinoxaline notified in G/SPS/N/JPN/1293 (dated 9 September 2024) were adopted and published on 10 February 2025.The specified MRLs are available as below:

Maximum residue limits (MRLs); +17

The proposed maximum residue limits (MRLs) for Chinomethionat notified in G/SPS/N/JPN/1299 (dated 4 October 2024) were adopted and published on 27 February 2025.The specified MRLs are available as below:

Maximum residue limits (MRLs); +17

The proposed maximum residue limits (MRLs) for Fenpropidin notified in G/SPS/N/JPN/1300 (dated 4 October 2024) were adopted and published on 27 February 2025.The specified MRLs are available as below:

Maximum residue limits (MRLs); +17

The proposed maximum residue limits (MRLs) for Fenitrothion notified in G/SPS/N/JPN/1282 (dated 9 September 2024) were adopted and published on 10 February 2025.The specified MRLs are available as below:

Maximum residue limits (MRLs); +17

The proposed maximum residue limits (MRLs) for Sulfadimethoxine notified in G/SPS/N/JPN/1285 (dated 9 September 2024) were adopted and published on 10 February 2025.The specified MRLs are available as below:

Maximum residue limits (MRLs); +17

The proposed maximum residue limits (MRLs) for Cartap, Thiocyclam and Bensultap notified in G/SPS/N/JPN/1298 (dated 4 October 2024) were adopted and published on 27 February 2025.The specified MRLs are available as below:

Maximum residue limits (MRLs); +17

The proposed maximum residue limits (MRLs) for Fluopyram notified in G/SPS/N/JPN/1301 (dated 4 October 2024) were adopted and published on 27 February 2025.The specified MRLs are available as below:

Maximum residue limits (MRLs); +17

The proposed maximum residue limits (MRLs) for Cyflumetofen notified in G/SPS/N/JPN/1278 (dated 9 September 2024) were adopted and published on 10 February 2025.The specified MRLs are available as below:

Maximum residue limits (MRLs); +17

The proposed maximum residue limits (MRLs) for Sulfachlorpyridazine notified in G/SPS/N/JPN/1283 (dated 9 September 2024) were adopted and published on 10 February 2025.The specified MRLs are available as below:

Maximum residue limits (MRLs); +17

The proposed maximum residue limits (MRLs) for Sulfamethoxazole notified in G/SPS/N/JPN/1288 (dated 9 September 2024) were adopted and published on 10 February 2025.The specified MRLs are available as below:

Maximum residue limits (MRLs); +17

The proposed maximum residue limits (MRLs) for 1-Naphthaleneacetic acid notified in G/SPS/N/JPN/1304 (dated 4 October 2024) were adopted and published on 27 February 2025.The specified MRLs are available as below:

Maximum residue limits (MRLs); +17

The proposed maximum residue limits (MRLs) for Imicyafos notified in G/SPS/N/JPN/1302 (dated 4 October 2024) were adopted and published on 27 February 2025.The specified MRLs are available as below:

Maximum residue limits (MRLs); +17

The proposed designation of substance used as an ingredient of agricultural chemicals and other chemical substances that is stipulated to be “The substance in food that does not pose any adverse health effect” for BLAD notified in G/SPS/N/JPN/1277 (dated 9 September 2024) was adopted and published on 10 February 2025.The specified designation is available as below:

Adoption/publication/entry into force of +17

The proposed maximum residue limits (MRLs) for Dibutylhydroxytoluene notified in G/SPS/N/JPN/1315 (dated 8 November 2024) were adopted and published on 27 February 2025.The specified MRLs are available as below:

Maximum residue limits (MRLs); +17
Page 5 of 71
Showing 81 to 100 of 1406 notifications